Hunter L. Little

Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy

PURPOSE To present evidence that systemic corticosteroid therapy may cause bilateral bullous serofibrinous exudative retinal detachment in some patients with idiopathic central serous chorioretinopathy. BACKGROUND Idiopathic central serous chorioretinopathy usually causes mild, transient loss of central vision, usually in otherwise healthy men with a type A personality. A few patients have permanent visual loss because of chronic and recurrent retinal detachment. The clinical findings in these patients may lead to incorrect diagnoses and use of corticosteroid therapy. METHODS The clinical and photographic records of three patients in whom bilateral bullous serofibrinous exudative retinal detachment associated with idiopathic central serous chorioretinopathy developed after treatment with systemic corticosteroids were reviewed. RESULTS Systemic corticosteroid treatment was instituted (1) as a prophylaxis to prevent exacerbation of the disease while undergoing surgery in the fellow eye, and (2) as the result of misdiagnoses of multifocal choroiditis and retinal vasculitis (Eales disease). Two of the patients had a history of chronic recurrent retinal detachments before institution of corticosteroid treatment. In one of these patients, bilateral chronic inferior retinal detachment developed, causing peripheral retinal vascular nonperfusion, retinal neovascularization, and vitreous hemorrhage. All three patients had severe permanent visual loss in one or both eyes. CONCLUSION The findings in these patients provide further evidence that systemic corticosteroid treatment may cause severe exacerbation of retinal detachment and lasting visual loss in some patients with idiopathic central serous retinopathy. Recognition of the atypical presentations of this disorder is important to avoid incorrect diagnoses and treatment.

The Effect of Pan-Retinal Photocoagulation on Rubeosis Iridis

Fifteen eyes of 11 patients with rubeosis iridis and angle neovascularization associated with retinal vascular disorders were treated with pan-retinal photocoagulation. In seven of the 15 eyes, the new vessels on the surface of the iris and in the angle regressed after pan-retinal photocoagulation therapy for disk neovascularization; five of the remaining eight eyes that were treated prospectively demonstrated similar involution of the rubeosis iridis. In three of the five preexisting peripheral anterior synechiae regressed and angle structures previously obscured became visible. Three to 36 months after therapy, three eyes developed a few new abnormal iris and angle vessels.

A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen.

PURPOSE The authors determined the effect of photocoagulation of drusen on visual acuity and progression to subretinal neovascular membranes (SRNV). METHODS One of paired eyes was randomized to photocoagulation with other eye to control in 27 patients having symmetrical maculopathy and visual acuities, aged 46 to 81 years (mean, 69.7 years); follow-up 1 to 6 years (mean, 3.2 years). RESULTS Final visual acuity was improved in treated eye or decreased in control eye in 12 patients, equal in 13 patients, and decreased in treated eye in 2 patients (P < 0.006). Progression to SRNV was less with treatment. CONCLUSION Laser photocoagulation of confluent soft macular drusen may improve long-term visual prognosis.

Retinal Injury Due to Industrial Laser Burns

Ocular industrial lasers burns in seven patients were analyzed as to cause, severity, and type of injury. Ocular damage ranged from minimal retinal burns to extensive areas of damage with commotio retinae and vitreous hemorrhage. Visual loss ranged from complete recovery without residual defect to a profound decrease in central acuity. The kinds of lasers causing these injuries were neodymium YAG, argon, krypton, and rhodamine dye. Severity of injury was related to several factors. Some degree of carelessness was involved in all injuries.

Alterations in Blood Elements in the Pathogenesis of Diabetic Retinopathy

The role of altered blood elements in the pathogenesis of retinal ischemia and diabetic retinopathy and the relationship to abnormal carbohydrate metabolism and to elevated levels of growth hormone are discussed. These changes involve red blood cells, platelets, plasma proteins, fibrinolytic response, and vascular endothelium. The significance of blood elements mediated by plasma is noted with aggregation of normal red cells when cross-matched with diabetic plasma and with intensive plasmapheresis, which caused red cell disaggregation and improvement of retinopathy. The relationship of metabolic control to diabetic retinopathy is reviewed and is evident by improvement of retinopathy occurring eight weeks after continuous subcutaneous infusion of insulin. A hypothesis is presented which integrates the multifactorial processes involved in the pathogenesis of diabetic retinopathy. Only through future research can one prove the implicated mechanisms in the pathogenesis of diabetic retinopathy and the role of strict metabolic control in altering the progression of retinopathy.

Laser treatment in fellow eyes with large drusen: Updated findings from a pilot randomized clinical trial

PURPOSE To update the findings from the Choroidal Neovascularization Prevention Trial (CNVPT) with respect to resolution of drusen, incidence of choroidal neovascularization, and visual function. DESIGN A multicenter, randomized, controlled, pilot clinical trial. PARTICIPANTS The 120 patients enrolled in the CNVPT. Patients had signs of choroidal neovascularization or retinal pigment epithelial detachment in 1 eye and had >/=10 large (>63- micro m) drusen in the contralateral, or fellow, eye. INTERVENTION The fellow eye of 59 patients was assigned randomly to argon green laser treatment consisting of multiple 100- micro m spots at least 750 micro m from the center of the fovea. The fellow eye of the remaining 61 patients was assigned randomly to observation. MAIN OUTCOME MEASURES Change in visual acuity was the primary outcome measure. Incidence of choroidal neovascularization, resolution of drusen, change in contrast threshold, change in critical print size for reading, and incidence of geographic atrophy were secondary outcome measures. RESULTS Throughout 4 years of follow-up, there were no statistically significant differences in change in visual acuity, contrast threshold, critical print size, or incidence of geographic atrophy. With additional follow-up, the large increase in the incidence of choroidal neovascularization observed within 18 months of treatment was maintained; however, by 30 months, the incidence in the two treatment groups was the same. Most drusen resolution in treated eyes occurred within 24 months of the initial treatment. Treated eyes that received higher-intensity laser burns had an increased risk of choroidal neovascularization. Among eyes developing choroidal neovascularization in each treatment group, most lesions (two thirds or more) were composed of occult neovascularization only. CONCLUSIONS Laser treatment as applied in the CNVPT caused an excess risk of choroidal neovascularization in the first year or so after treatment. The increased early incidence of choroidal neovascularization was not associated with either a harmful or beneficial effect in this pilot study.

Infrequency of Retinal Neovascularization Following Central Retinal Vein Occlusion

Forty-eight patients with the clinical diagnosis of central retinal vein occlusion and ten surgically enulceated eyes with central retinal vein occlusion documented by histopathologic examination were studied and reviewed. Retinal neovascularization developed in only one of the ten eyes. Rubeosis iridis occurred in 14% (7) of the clinical cases and in all of the histopathologic cases. Ten eyes with neovascular glaucoma, enucleated following central retinal vein occlusion, showed absence of retinal endothelial cells. The absence of retinal capillary endothelial cells is significant in explaining the rare occurrence of retinal neovascularization following central retinal vein occlusion. However, the small number of cases may reflect a biased result. Further studies of more cases over a longer period are required to reach the final conclusion.

Techniques of Argon Laser Photocoagulation of Diabetic Disk New Vessels

Four argon laser techniques have been evaluated in the eradication of diabetic disk neovascularization: focal (nonfeeder) photocoagulation, feeder-frond photocoagulation alone, panretinal photocoagulation alone, and feeder-frond treatment combined with panretinal photocoagulation. Focal photocoagulation was dangerous and the least effective technique in preventing recurrence of neovascularization. Feeder-frond photocoagulation was effective initially, but was associated with a high incidence of recurrent neovascularization. Panretinal photocoagulation and panretinal photocoagulation combined with feeder-frond treatment produced results superior to those obtained with the two earlier techniques. The best results were obtained with combined feeder-frond and panretinal photocoagulation done concurrently. Early diagnosis, aggressive photocoagulation therapy, and close follow-up were essential in order to obtain good results.

Treatment of Proliferative Diabetic Retinopathy Long-term Results of Argon Laser Photocoagulation

Panretinal photocoagulation (PRP) is the treatment of choice for proliferative diabetic retinopathy. Indications for treatment are the presence of disc new vessels or the presence of new vessels elsewhere with hemorrhage. Rubeosis iridis and retinal neovascularization undergo involution following panretinal photocoagulation. The long-term visual results are excellent excepting for eyes with diffuse diabetic retinal ischemia. Long-term follow-up and repeat photocoagulation as needed are advised.

Argon Laser Therapy of Diabetic Retinopathy

Diabetes mellitus is the second leading cause of new adult blindness in the United States; retinopathy accounts for 84% of blindness in diabetics. Over 60 % of diabetics develop retinopathy after having had diabetes for 15 or 20 years (Goldberg & Fine, 1968). These data indicate the significance of diabetic retinopathy. Proliferative retinopathy is responsible for blindness in over 90 % of the blind diabetics under 40 (Whittington, 1964). Exudative retinopathy accounts for most blindness in the elder diabetics.